Cape Coral, Florida, United States
In 1991, Moroney & Gill, Inc. launched a unique advertising and marketing agency that focused on customer service without the typical retainer-fee based billing system. This unique billing system ensured that the agency was accountable to the client to get the job done right the first time. This flat-fee system is called “accountabilling™”. "When you don't count hours, there is no risk for the client in getting the creative they want. We are accountable to get the job done right because we can't use hourly charges to sustain us. We strive for the market success of the products we represent and don't have to worry about a agency-client relationship burdened by cost discussions." Kevin Moroney Moroney & Gill, Inc. remains the first and only “No Fee” healthcare advertising and consultancy agency. Please visit www.moroneyandgill.com for a complete list of clients and services. Kevin Moroney is CEO and President. He can be reached at 239 410 4981. Specialties: Branding, Positioning, Launch Strategies, Full Service Advertising: Rx Medical, Aesthetics, Dermatology, Health and Beauty, Leisure, Consumer and Professional OTC support. Company and product Brand Architecture, developing Rx launch plans and algorithms, creative development of all collateral and advertising tools.
Principal and founder of Morgan Graff & Gold, Inc., MG&G advertising, Moroney & Gill, Inc. Specializing in Advertising for Rx Healthcare, Consumer, DTC, and OTC. Large focus on branding Rx products and companies for strategic and competitive advantage. Key clients remain Fortune 500 companies and start-up divisions. All services are charged as a flat-fee with no hourly charges.
Account Supervisor for Zantac Account with Glaxo. 1st $1 Billion product in the US.
Responsible for Worldwide Advertising of Infectious Disease Business Group Rx products. Lead a team of Communication Specialists responsible for writing, implementing, and budgeting yearly communication plans for multiple products. Managed a total of 15 Rx products. Responsible for large promotional budgets. Also served as Product Manager for the launch of a new US cardiovascular product.
Responsible for the Launch of Rogaine. 1st Rx to OTC switch product in the US. Disease and product focus in CNS; Xanax and Halcion, Diabetes, Monoclonal Antibodies, Corticosteroids, Dermatology, and others.
Hospital and General Sales in St. Petersburg FL